144 related articles for article (PubMed ID: 3343972)
1. Purification of Par j I, the major allergen of Parietaria judaica pollen.
Ayuso R; Polo F; Carreira J
Mol Immunol; 1988 Jan; 25(1):49-56. PubMed ID: 3343972
[TBL] [Abstract][Full Text] [Related]
2. Purification and characterization of Par o I, major allergen of Parietaria officinalis pollen.
Oreste U; Coscia MR; Scotto d'Abusco A; Santonastaso V; Ruffilli A
Int Arch Allergy Appl Immunol; 1991; 96(1):19-27. PubMed ID: 1752693
[TBL] [Abstract][Full Text] [Related]
3. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
Rossi RE; Monasterolo G; Coco G; Operti D
Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
[TBL] [Abstract][Full Text] [Related]
4. HPLC purification of the main allergen of Parietaria judaica pollen.
Polo F; Ayuso R; Carreira J
Mol Immunol; 1990 Feb; 27(2):151-7. PubMed ID: 2320010
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity to Parietaria officinalis and Parietaria judaica pollen allergens in a Spanish population.
Dreborg S; Basomba A; Einarsson R
Allergol Immunopathol (Madr); 1986; 14(6):499-508. PubMed ID: 3825837
[TBL] [Abstract][Full Text] [Related]
6. Isolation by mAb based affinity chromatography of two Par j I isoallergens. Comparison of their physicochemical, immunochemical and allergenic properties.
Ayuso R; Carreira J; Lombardero M; Duffort O; Peris A; Basomba A; Polo F
Mol Immunol; 1993 Oct; 30(15):1347-54. PubMed ID: 7694085
[TBL] [Abstract][Full Text] [Related]
7. Isolation of the major IgE-binding protein from Parietaria judaica pollen using monoclonal antibodies.
Corbí AL; Ley V; Sanchez-Madrid F; Carreira J
Mol Immunol; 1985 Sep; 22(9):1081-9. PubMed ID: 2415813
[TBL] [Abstract][Full Text] [Related]
8. A sensitive monoclonal antibody-based enzyme-linked immunosorbent assay to quantify Parietaria judaica major allergens, Par j 1 and Par j 2.
Arilla MC; González-Rioja R; Ibarrola I; Mir A; Monteseirín J; Conde J; Martínez A; Asturias JA
Clin Exp Allergy; 2006 Jan; 36(1):87-93. PubMed ID: 16393270
[TBL] [Abstract][Full Text] [Related]
9. Identification of IgE binding polypeptides cross-reactive with the Parietaria judaica main allergenic polypeptide.
Corbi AL; Ayuso R; Carreira J
Mol Immunol; 1986 Dec; 23(12):1357-63. PubMed ID: 2434845
[TBL] [Abstract][Full Text] [Related]
10. Determinations of Par j 1 by a competitive enzyme immunoassay using human specific IgE and IgG. Validation by skin prick testing.
Boluda L; Casanovas M; Prieto JL; Fernández-Caldas E
J Investig Allergol Clin Immunol; 1998; 8(4):207-13. PubMed ID: 9777534
[TBL] [Abstract][Full Text] [Related]
11. Role of carbohydrate moieties in cross-reactivity between different components of Parietaria judaica pollen extract.
Mucci N; Liberatore P; Federico R; Forlani F; Di Felice G; Afferni C; Tinghino R; De Cesare F; Pini C
Allergy; 1992 Aug; 47(4 Pt 2):424-30. PubMed ID: 1280917
[TBL] [Abstract][Full Text] [Related]
12. Par j 1 and Par j 2, the major allergens from Parietaria judaica pollen, have similar immunoglobulin E epitopes.
Asturias JA; Gómez-Bayón N; Eseverri JL; Martínez A
Clin Exp Allergy; 2003 Apr; 33(4):518-24. PubMed ID: 12680870
[TBL] [Abstract][Full Text] [Related]
13. Allergens of Parietaria judaica pollen--I. Purification and characterization of a hapten and a low molecular weight allergenic peptide.
Feo S; Cocchiara R; Geraci D
Mol Immunol; 1984 Jan; 21(1):25-36. PubMed ID: 6423971
[TBL] [Abstract][Full Text] [Related]
14. Isolation, expression and immunological characterization of a calcium-binding protein from Parietaria pollen.
Bonura A; Gulino L; Trapani A; Di Felice G; Tinghino R; Amoroso S; Geraci D; Valenta R; Westritschnig K; Scala E; Mari A; Colombo P
Mol Immunol; 2008 May; 45(9):2465-73. PubMed ID: 18289680
[TBL] [Abstract][Full Text] [Related]
15. Quantitation of the major allergen of several Parietaria pollens by an anti-Par 1 monoclonal antibody-based ELISA. Analysis of crossreactivity among purified Par j 1, Par o 1 and Par m 1 allergens.
Ayuso R; Carreira J; Polo F
Clin Exp Allergy; 1995 Oct; 25(10):993-9. PubMed ID: 8556571
[TBL] [Abstract][Full Text] [Related]
16. Purification of Parj I, a major allergen from Parietaria, judaica pollen.
Cocchiara R; Locorotondo G; Parlato A; Guarnotta G; Ronchi S; Albeggiani G; Amoroso S; Falagiani P; Geraci D
Int Arch Allergy Appl Immunol; 1989; 90(1):84-90. PubMed ID: 2478488
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy with a mass unit Parietaria judaica extract: a tolerance study with evidence of immunological changes to the major allergen Par j 1.
García Villalmanzo I; Hernández MD; Campos A; Giner AM; Polo F; Cortés C; Basomba A
J Investig Allergol Clin Immunol; 1999; 9(5):321-9. PubMed ID: 10582201
[TBL] [Abstract][Full Text] [Related]
18. The recombinant major allergen of Parietaria judaica and its hypoallergenic variant: in vivo evaluation in a murine model of allergic sensitization.
Orlandi A; Grasso F; Corinti S; Marinaro M; Bonura A; Boirivant M; Colombo P; Di Felice G
Clin Exp Allergy; 2004 Mar; 34(3):470-7. PubMed ID: 15005743
[TBL] [Abstract][Full Text] [Related]
19. Isolation and purification of a major allergen from Parietaria officinalis pollen.
Giuliani A; Pini C; Bonini S; Mucci N; Ferroni L; Vicari G
Allergy; 1987 Aug; 42(6):434-40. PubMed ID: 3310716
[TBL] [Abstract][Full Text] [Related]
20. Identification of cross-reactive and genuine Parietaria judaica pollen allergens.
Stumvoll S; Westritschnig K; Lidholm J; Spitzauer S; Colombo P; Duro G; Kraft D; Geraci D; Valenta R
J Allergy Clin Immunol; 2003 May; 111(5):974-9. PubMed ID: 12743560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
